Literature DB >> 21611785

p53 regulates Ki-67 promoter activity through p53- and Sp1-dependent manner in HeLa cells.

Mei-Juan Wang1, Dong-Sheng Pei, Guo-Wei Qian, Xiao-Xing Yin, Qian Cheng, Lian-Tao Li, Hui-Zhong Li, Jun-Nian Zheng.   

Abstract

The expression of the human Ki-67 protein, which is strictly associated with cell proliferation, is regulated by a variety of cellular mediators. In this study, we studied the effects of p53 on Ki-67 promoter in HeLa cells using luciferase reporter assay. The results showed that: (1) p53 inhibited Ki-67 promoter activity in a dose-dependent manner, (2) the p53-binding motifs mediated part of the transcriptional repression of Ki-67 promoter through a sequence-specific interaction with p53, (3) p53 was able to repress the Sp1-stimulated Ki-67 promoter activity, and (4) the Sp1-binding sites were responsible for the p53-mediated transcriptional repression of Ki-67 promoter. In conclusion, p53 inhibited Ki-67 promoter activity via p53- and Sp1-dependent pathways, and the interaction between p53 and Sp1 might be involved in the transcriptional regulatory mechanisms.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21611785     DOI: 10.1007/s13277-011-0191-4

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  32 in total

1.  Apoptosis and cell proliferation in the metaplasia-dysplasia-carcinoma-sequence of Barrett's esophagus.

Authors:  U Halm; A Tannapfel; B Breitung; M Breidert; C W Wittekind; J Mössner
Journal:  Hepatogastroenterology       Date:  2000 Jul-Aug

2.  Co-expression of p53 and Ki67 and lack of EBV expression in oral squamous cell carcinoma.

Authors:  Anak Iamaroon; Udomrat Khemaleelakul; Surawut Pongsiriwet; Jarupan Pintong
Journal:  J Oral Pathol Med       Date:  2004-01       Impact factor: 4.253

3.  A critical role of Sp1 transcription factor in regulating the human Ki-67 gene expression.

Authors:  Hui Tian; Guo-Wei Qian; Wang Li; Fei-Fei Chen; Jie-Hui Di; Bao-Fu Zhang; Dong-Sheng Pei; Ping Ma; Jun-Nian Zheng
Journal:  Tumour Biol       Date:  2010-10-21

4.  Transcriptional repression by p53 involves molecular interactions distinct from those with the TATA box binding protein.

Authors:  G Farmer; P Friedlander; J Colgan; J L Manley; C Prives
Journal:  Nucleic Acids Res       Date:  1996-11-01       Impact factor: 16.971

5.  The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines.

Authors:  M Scheffner; K Münger; J C Byrne; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

6.  Localization of gene for human p53 tumour antigen to band 17p13.

Authors:  M Isobe; B S Emanuel; D Givol; M Oren; C M Croce
Journal:  Nature       Date:  1986 Mar 6-12       Impact factor: 49.962

7.  Physical and functional interactions between members of the tumour suppressor p53 and the Sp families of transcription factors: importance for the regulation of genes involved in cell-cycle arrest and apoptosis.

Authors:  George Koutsodontis; Eleftheria Vasilaki; Wan-Chih Chou; Paraskevi Papakosta; Dimitris Kardassis
Journal:  Biochem J       Date:  2005-07-15       Impact factor: 3.857

8.  Transcriptional regulation of the human DNA polymerase delta catalytic subunit gene POLD1 by p53 tumor suppressor and Sp1.

Authors:  B Li; M Y Lee
Journal:  J Biol Chem       Date:  2001-05-25       Impact factor: 5.157

Review 9.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

10.  Analysis of human p53 proteins and mRNA levels in normal and transformed cells.

Authors:  G Matlashewski; L Banks; D Pim; L Crawford
Journal:  Eur J Biochem       Date:  1986-02-03
View more
  6 in total

1.  A dual-regulated oncolytic adenovirus expressing interleukin-24 sensitizes melanoma cells to temozolomide via the induction of apoptosis.

Authors:  Guan Jiang; Ai-Jun Jiang; Qian Cheng; Hui Tian; Lian-Tao Li; Jun-Nian Zheng
Journal:  Tumour Biol       Date:  2013-02-21

Review 2.  Ki67 targeted strategies for cancer therapy.

Authors:  C Yang; J Zhang; M Ding; K Xu; L Li; L Mao; J Zheng
Journal:  Clin Transl Oncol       Date:  2017-10-20       Impact factor: 3.340

3.  LARP1 post-transcriptionally regulates mTOR and contributes to cancer progression.

Authors:  M Mura; T G Hopkins; T Michael; N Abd-Latip; J Weir; E Aboagye; F Mauri; C Jameson; J Sturge; H Gabra; M Bushell; A E Willis; E Curry; S P Blagden
Journal:  Oncogene       Date:  2014-12-22       Impact factor: 9.867

4.  Potent anti-tumour activity of a novel conditionally replicating adenovirus for melanoma via inhibition of migration and invasion.

Authors:  G Jiang; C-S Yang; D Xu; C Sun; J-N Zheng; T-C Lei; Y-Q Liu
Journal:  Br J Cancer       Date:  2014-04-08       Impact factor: 7.640

5.  Quantitative iTRAQ LC-MS/MS Proteomics Reveals Transcription Factor Crosstalk and Regulatory Networks in Hypopharyngeal Squamous Cell Carcinoma.

Authors:  Gangcai Zhu; Gengming Cai; Yong Liu; Haolei Tan; Changyun Yu; Meiling Huang; Ming Wei; She Li; Xiangning Cui; Donghai Huang; Yongquan Tian; Xin Zhang
Journal:  J Cancer       Date:  2014-06-16       Impact factor: 4.207

6.  Ki-67 gene expression.

Authors:  Sigrid Uxa; Paola Castillo-Binder; Robin Kohler; Konstanze Stangner; Gerd A Müller; Kurt Engeland
Journal:  Cell Death Differ       Date:  2021-06-28       Impact factor: 15.828

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.